UniProt ID | CXAR_HUMAN | |
---|---|---|
UniProt AC | P78310 | |
Protein Name | Coxsackievirus and adenovirus receptor | |
Gene Name | CXADR | |
Organism | Homo sapiens (Human). | |
Sequence Length | 365 | |
Subcellular Localization |
Isoform 1: Cell membrane Single-pass type I membrane protein . Basolateral cell membrane Single-pass type I membrane protein . Cell junction, tight junction . Cell junction, adherens junction . In epithelial cells localizes to the apical junction |
|
Protein Description | Component of the epithelial apical junction complex that may function as a homophilic cell adhesion molecule and is essential for tight junction integrity. Also involved in transepithelial migration of leukocytes through adhesive interactions with JAML a transmembrane protein of the plasma membrane of leukocytes. The interaction between both receptors also mediates the activation of gamma-delta T-cells, a subpopulation of T-cells residing in epithelia and involved in tissue homeostasis and repair. Upon epithelial CXADR-binding, JAML induces downstream cell signaling events in gamma-delta T-cells through PI3-kinase and MAP kinases. It results in proliferation and production of cytokines and growth factors by T-cells that in turn stimulate epithelial tissues repair.; (Microbial infection) Acts as a receptor for adenovirus type C.; (Microbial infection) Acts as a receptor for Coxsackievirus B1 to B6.. | |
Protein Sequence | MALLLCFVLLCGVVDFARSLSITTPEEMIEKAKGETAYLPCKFTLSPEDQGPLDIEWLISPADNQKVDQVIILYSGDKIYDDYYPDLKGRVHFTSNDLKSGDASINVTNLQLSDIGTYQCKVKKAPGVANKKIHLVVLVKPSGARCYVDGSEEIGSDFKIKCEPKEGSLPLQYEWQKLSDSQKMPTSWLAEMTSSVISVKNASSEYSGTYSCTVRNRVGSDQCLLRLNVVPPSNKAGLIAGAIIGTLLALALIGLIIFCCRKKRREEKYEKEVHHDIREDVPPPKSRTSTARSYIGSNHSSLGSMSPSNMEGYSKTQYNQVPSEDFERTPQSPTLPPAKVAAPNLSRMGAIPVMIPAQSKDGSIV | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
88 | Ubiquitination | DDYYPDLKGRVHFTS CCCCCCCCCCEEEEC | 52.64 | 29967540 | |
88 | Acetylation | DDYYPDLKGRVHFTS CCCCCCCCCCEEEEC | 52.64 | 20167786 | |
94 | Phosphorylation | LKGRVHFTSNDLKSG CCCCEEEECCCCCCC | 16.25 | 21082442 | |
99 | Acetylation | HFTSNDLKSGDASIN EEECCCCCCCCCEEE | 56.08 | 20167786 | |
100 | Phosphorylation | FTSNDLKSGDASINV EECCCCCCCCCEEEE | 49.56 | - | |
106 | N-linked_Glycosylation | KSGDASINVTNLQLS CCCCCEEEEEEEEHH | 31.87 | UniProtKB CARBOHYD | |
108 | Phosphorylation | GDASINVTNLQLSDI CCCEEEEEEEEHHHC | 26.23 | 21082442 | |
121 | Acetylation | DIGTYQCKVKKAPGV HCEEEEEEEEECCCC | 41.38 | 20167786 | |
151 | Phosphorylation | ARCYVDGSEEIGSDF CEEEECCCCCCCCCC | 27.82 | 24173317 | |
177 | Ubiquitination | PLQYEWQKLSDSQKM CCEEEEEECCCCCCC | 51.54 | 29967540 | |
178 (in isoform 4) | Phosphorylation | - | 4.05 | 24719451 | |
182 (in isoform 4) | Phosphorylation | - | 51.57 | 24719451 | |
201 | N-linked_Glycosylation | SSVISVKNASSEYSG HCEEEEECCCCCCCE | 42.79 | UniProtKB CARBOHYD | |
203 | Phosphorylation | VISVKNASSEYSGTY EEEEECCCCCCCEEE | 32.85 | 25907765 | |
204 | Phosphorylation | ISVKNASSEYSGTYS EEEECCCCCCCEEEE | 37.84 | 25907765 | |
206 | Phosphorylation | VKNASSEYSGTYSCT EECCCCCCCEEEEEE | 17.85 | 25907765 | |
207 | Phosphorylation | KNASSEYSGTYSCTV ECCCCCCCEEEEEEE | 22.17 | 25907765 | |
209 | Phosphorylation | ASSEYSGTYSCTVRN CCCCCCEEEEEEEEC | 13.30 | 25907765 | |
210 | Phosphorylation | SSEYSGTYSCTVRNR CCCCCEEEEEEEECC | 12.79 | 25907765 | |
211 | Phosphorylation | SEYSGTYSCTVRNRV CCCCEEEEEEEECCC | 11.80 | 25907765 | |
213 | Phosphorylation | YSGTYSCTVRNRVGS CCEEEEEEEECCCCC | 19.29 | 25907765 | |
230 (in isoform 5) | Phosphorylation | - | 5.85 | 24719451 | |
233 | Phosphorylation | RLNVVPPSNKAGLIA EEEECCCCCCHHHHH | 44.91 | 21406692 | |
234 (in isoform 5) | Phosphorylation | - | 43.93 | 24719451 | |
259 | S-palmitoylation | LIGLIIFCCRKKRRE HHHHHHHHHHHHHHH | 1.22 | 12021372 | |
260 | S-palmitoylation | IGLIIFCCRKKRREE HHHHHHHHHHHHHHH | 5.07 | 12021372 | |
268 | Ubiquitination | RKKRREEKYEKEVHH HHHHHHHHHHHHHCC | 54.69 | 23000965 | |
271 | Ubiquitination | RREEKYEKEVHHDIR HHHHHHHHHHCCHHH | 63.04 | 23000965 | |
274 | Ubiquitination | EKYEKEVHHDIREDV HHHHHHHCCHHHHCC | 17.62 | 21906983 | |
285 | Ubiquitination | REDVPPPKSRTSTAR HHCCCCCCCCCCHHH | 59.34 | 29967540 | |
286 | Phosphorylation | EDVPPPKSRTSTARS HCCCCCCCCCCHHHH | 46.71 | 26074081 | |
288 | Phosphorylation | VPPPKSRTSTARSYI CCCCCCCCCHHHHHC | 37.20 | 29449344 | |
289 | Phosphorylation | PPPKSRTSTARSYIG CCCCCCCCHHHHHCC | 20.96 | 30576142 | |
290 | Phosphorylation | PPKSRTSTARSYIGS CCCCCCCHHHHHCCC | 26.02 | 29449344 | |
293 | Phosphorylation | SRTSTARSYIGSNHS CCCCHHHHHCCCCCC | 20.73 | 21945579 | |
294 | Phosphorylation | RTSTARSYIGSNHSS CCCHHHHHCCCCCCC | 12.07 | 21945579 | |
297 | Phosphorylation | TARSYIGSNHSSLGS HHHHHCCCCCCCCCC | 23.08 | 21945579 | |
300 | Phosphorylation | SYIGSNHSSLGSMSP HHCCCCCCCCCCCCC | 31.35 | 21945579 | |
301 | Phosphorylation | YIGSNHSSLGSMSPS HCCCCCCCCCCCCCC | 29.24 | 21945579 | |
304 | Phosphorylation | SNHSSLGSMSPSNME CCCCCCCCCCCCCCC | 22.75 | 21945579 | |
306 | Phosphorylation | HSSLGSMSPSNMEGY CCCCCCCCCCCCCCC | 27.20 | 21945579 | |
308 | Phosphorylation | SLGSMSPSNMEGYSK CCCCCCCCCCCCCCC | 41.31 | 21945579 | |
313 | Phosphorylation | SPSNMEGYSKTQYNQ CCCCCCCCCCCCCCC | 8.16 | 21945579 | |
314 | Phosphorylation | PSNMEGYSKTQYNQV CCCCCCCCCCCCCCC | 39.83 | 21945579 | |
315 (in isoform 2) | Ubiquitination | - | 31.03 | 21906983 | |
315 (in isoform 1) | Ubiquitination | - | 31.03 | 21906983 | |
315 | Ubiquitination | SNMEGYSKTQYNQVP CCCCCCCCCCCCCCC | 31.03 | 22817900 | |
316 | Phosphorylation | NMEGYSKTQYNQVPS CCCCCCCCCCCCCCH | 30.28 | 24732914 | |
318 | Phosphorylation | EGYSKTQYNQVPSED CCCCCCCCCCCCHHH | 16.88 | 25159151 | |
319 | Ubiquitination | GYSKTQYNQVPSEDF CCCCCCCCCCCHHHH | 26.93 | 21906983 | |
323 | Phosphorylation | TQYNQVPSEDFERTP CCCCCCCHHHHCCCC | 51.44 | 19664994 | |
329 | Phosphorylation | PSEDFERTPQSPTLP CHHHHCCCCCCCCCC | 20.62 | 30266825 | |
332 | Phosphorylation | DFERTPQSPTLPPAK HHCCCCCCCCCCHHH | 22.51 | 19664994 | |
334 | Phosphorylation | ERTPQSPTLPPAKVA CCCCCCCCCCHHHHC | 58.08 | 30266825 | |
339 | Ubiquitination | SPTLPPAKVAAPNLS CCCCCHHHHCCCCCC | 37.87 | 29967540 | |
339 | Acetylation | SPTLPPAKVAAPNLS CCCCCHHHHCCCCCC | 37.87 | 7675287 | |
345 | Ubiquitination | AKVAAPNLSRMGAIP HHHCCCCCCCCCCCC | 3.15 | 29967540 | |
346 | Phosphorylation | KVAAPNLSRMGAIPV HHCCCCCCCCCCCCE | 27.19 | 28355574 | |
350 (in isoform 6) | Phosphorylation | - | 8.12 | 30631047 | |
359 | Phosphorylation | PVMIPAQSKDGSIV- CEEEECCCCCCCCC- | 34.52 | 29514088 | |
360 | Ubiquitination | VMIPAQSKDGSIV-- EEEECCCCCCCCC-- | 54.77 | 29967540 | |
360 (in isoform 1) | Ubiquitination | - | 54.77 | 21906983 | |
363 | Phosphorylation | PAQSKDGSIV----- ECCCCCCCCC----- | 30.25 | 28258704 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of CXAR_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of CXAR_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
EWS_HUMAN | EWSR1 | physical | 16189514 | |
GRHPR_HUMAN | GRHPR | physical | 22939629 | |
NCOA1_HUMAN | NCOA1 | physical | 15572376 | |
NCOR1_HUMAN | NCOR1 | physical | 15572376 | |
JAML_HUMAN | AMICA1 | physical | 21982860 | |
CXAR_HUMAN | CXADR | physical | 21982860 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-332, AND MASSSPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-306 AND SER-332, ANDMASS SPECTROMETRY. | |
"Large-scale characterization of HeLa cell nuclear phosphoproteins."; Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J.,Li J., Cohn M.A., Cantley L.C., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-332, AND MASSSPECTROMETRY. |